Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Stroke-2019

About Stroke 2019

We take immense pleasure in inviting all the participants from all over the world to attend the Neuroscience conference entitled “6th Annual Conference on Stroke and Neurological disorders ” to be held on November 25-26, 2019 in Abu Dhabi, UAE.

Stroke 2019 has been planning and aiming to stimulate new techniques for the treatment of Stroke and Neurological disorders that would be beneficial for the neurosurgery and other neurological issues.

The conference will be coordinated around the theme ‘Emerging Concepts, Progressions and Awareness in Neurological Disorders and Stroke.

Our goal is to bring together worldwide distinguished academics in the field of Neurology and Brain to exchange and share meaningful experiences of various treatment procedures for Neurological Disorders and Stroke.

Scope and Importance

While more people are surviving strokes, many still face long-term disability. Stroke 2019 provides a platform for all the Neurology professionals, Researchers and Scientists to share knowledge and overcome this disorder by Innovative and Nobel ideas in Diagnosis and Treatment.

Target Audience

  • Neurologists and Researchers
  • Neurology Faculty and Students
  • Doctors and Scientists
  • Universities, Associations and Societies
  • Students and Research Scholars
  • Business Delegates
  • Product Manufacturer

 

Sessions/ Tracks

Track 1: Stroke and Mental Health

Though the effects of stroke are unpredictable, mood disorders such as depression, anxiety and pseudo-bulbar affect (PBA) are equally common. Researchers are actively investigating if certain kinds of strokes or strokes in certain areas of the brain produce mood disorders. So far, studies suggest that simply having a stroke increases the risk of either anxiety or depression, or having both. Research indicates that PBA is more common in survivors of the brainstem stroke, but it can occur in strokes in other areas. Depression affects between one- and two-thirds of stroke survivors. It’s characterized by feelings of overarching sadness, lack of pleasure in activities that were before enjoyed, or changes in eating and sleeping patterns. On other hands, anxiety occurs when a survivor focuses on worries and concerns. “They go over them again and again in their minds but without necessarily reaching a conclusion.  Anxiety affects about 20 per cent of survivors.  PBA is characterized by a mismatch between feelings and expression – laughing at a funeral, crying at a joke. PBA hasn’t been investigated as much as depression or anxiety, but it’s not uncommon, impacting 28 to 52 per cent of stroke survivors, according to studies. Mood disorders significantly alter the lives of survivors and their families. Because crying or a lack of emotions characterize the disorders, it’s best to identify them accurately and receive treatment based on a psychological assessment. A mental health professional talks with the survivor to determine their internal state of mind and their behaviour.

Track 2: Neurological Disorders

According to a survey, there are more than 600 neurological disorders. Neurological disorders are diseases that affect the brain and the central and autonomic nervous systems. In recognizing the signs and symptoms of neurological problems, it is first important to differentiate the many types of neurological disorders. The World Health Organization reports that various types of neurological disorders affect millions of people around the world, including 24 million that suffer from Alzheimer’s disease and 326 million who experience migraines. If you suspect that you or a loved one may be suffering from one of these issues, you may also be wondering about what causes a neurological disorder. The causes of such dysfunction can be quite diverse. Both the spinal cord and brain are insulated by abundant membranes that can be vulnerable to force and pressure. The peripheral nerves located deep under the skin can also be vulnerable to damage. Neurological disorders can affect a whole neurological pathway or a single neuron. Even a small disturbance to a neuron’s structural pathway can result in dysfunction

Track 3: Stroke and Cardiovascular Diseases

Cerebrovascular disease is a medical condition that affects the blood vessels of the brain and the cerebral circulation. The arteries supplying oxygen and nutrients to the brain are usually getting damaged in these disorders. The most common type of cerebrovascular disease is an ischemic stroke or mini-stroke and sometimes a haemorrhagic stroke. High blood pressure (Hypertension) is the most important contributing risk factor for stroke and cerebrovascular diseases as it can change the structure of blood vessels and result in atherosclerosis. Atherosclerosis is a condition where the blood vessels narrow in the brain, resulting in decreased cerebral perfusion. Narrowed cerebral arteries may lead to ischemic stroke, but continually elevated blood pressure can also cause tearing of vessels, leading to a haemorrhagic stroke. Stroke is a risk factor for coronary heart disease. Coronary heart disease and stroke share many of the same risk factors such as high LDL (“bad”) cholesterol levels, low HDL (“good”) cholesterol levels, high blood pressure, smoking, diabetes, physical inactivity, and being overweight or obese. Individuals with coronary heart disease, angina, or who have had a heart attack due to atherosclerosis, have more than twice the risk of stroke than those who haven’t. If you have atherosclerosis in the coronary arteries you are very likely to have atherosclerosis in other parts of your body. Atherosclerosis is often referred to as "hardening of the arteries." The word comes from the Greek words athero (meaning gruel or paste) and sclerosis (hardness). In atrial fibrillation, the upper chambers of the heart (the atria) quiver instead of beating effectively to move blood into the ventricle.

Track 4: Brain and Neuromuscular Diseases

A healthy brain and nervous system control your body functions so you can have full command over your senses, muscles, and intelligence. Despite the amazing capacities of the human brain and nerves, they are vulnerable to damage just like every other part of our bodies. Strokes, concussions, Alzheimer’s and many other brain problems affect about 50 million Americans. The multitude of brain injuries and illnesses strike different people based on the risk factors of their genetics, age and lifestyle. The severity of impairment and the availability of treatment vary widely. Knowledge of brain and nerve health has advanced rapidly in recent decades. Many new treatments and medicines are available to treat various disorders. Still, the best thing for your brain is to keep it physically and mentally active while eating nutritious food and getting plenty of social interaction. Neuromuscular diseases are a wide-ranging group of diseases that affect nerves and muscles. They can arise following an injury, from other diseases such as diabetes, or from inherited or autoimmune diseases. Neuromuscular diseases can cause pain, weakness, numbness, and sometimes more severe symptoms such as difficulty talking, eating, or breathing. Neuromuscular diseases include Amyotrophic lateral sclerosis (Lou Gehrig's Disease), Guillain Barre syndrome, Muscular dystrophy, Myasthenia gravis, Myopathy.

Track 5: Stroke Rehabilitation and Recovery

Rehabilitation is given for a long period of time to improve function so that the stroke survivor can become as independent as possible. This must be accomplished in a way that preserves dignity and motivates the survivor to relearn basic skills that the stroke may have impaired - skills like bathing, eating, dressing and walking. Rehabilitation starts in the hospital as soon as possible following a stroke. The rehab team includes Physiatrist, Neurologist, Rehabilitation Nurse, Physical Therapist, Occupational Therapist and Speech-Language Pathologists. Recovery following a stroke starts as the brain responds to what’s happened. The brain’s functions will be adjusted to account for the death or decrease in the affected area. If a stroke victim receives medical attention within three hours of suffering the stroke they may be a candidate to receive medication to break up clots via an IV-drip. This clot-destroying medicine can significantly reduce negative long-term disabilities in the patient. The rehabilitation process begins after doctors have assessed and treated any critical conditions in the patient, and taken precautionary steps to prevent additional complications. This means rehabilitation could begin during the patient’s first hospital visit, which will increase the likelihood of recovering the damaged body and brain function. The first three months of recovery are when a patient will see the most development, and gains may happen rapidly over time. Some stroke survivors will continue to progress after this period; however, if the brain stem was affected during the stroke recovery could take up to a year or even longer

Track 6: Epidemiology

Epidemiology is a scientific discipline with sound methods of scientific inquiry at its foundation. Epidemiology is data-driven and relies on a systematic and unbiased method to the collection, analysis, and clarification of data. Basic epidemiologic methods tend to rely on the careful remark and use of valid comparison groups to assess whether what was observed, such as the number of cases of the disease in a specific area during a specific time period or the frequency of an exposure among persons with the disease, differs from what might be expected. However, epidemiology also draws on methods from other scientific fields, including biostatistics and informatics, with biologic, economic, social, and behavioural sciences. In fact, epidemiology is often described as the basic science of public health, and for good reason. First, epidemiology is a quantitative discipline that relies on a working knowledge of probability, statistics, and sound research methods. Second, epidemiology is a method of causal intellectual based on developing and testing hypotheses grounded in such scientific fields as biology, behavioural sciences, physics, and ergonomics to explain health-related behaviours, states, and events. However, epidemiology is not just a research activity but an integral component of public health, providing the foundation for directing practical and suitable public health action based on this science and causal reasoning.

Track 7: Neurophysiology and Neurodegeneration

Neurophysiology is a branch of physiology and neuroscience that is concerned with the study of the functioning of the nervous system. The primary tools of basic neurophysiological research include electrophysiological recordings, for example, voltage clamp, patch clamp, extracellular single-unit recording and recording of local field potentials, as well as some of the methods of apoptogenesis, calcium imaging, and molecular biology. Neurophysiology is related to electrophysiology, neuroanatomy, psychology and mathematical neuroscience. Neurodegeneration is the process of progressive damage of structure or function of neurons, with the death of neurons. Many neurodegenerative diseases – including amyotrophic lateral sclerosis, Parkinson's, Alzheimer's, and Huntington's – occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells. As research progresses, many similarities appear that relate these diseases to one another on a sub-cellular level. Discovering these resemblances offers hope for therapeutic advances that could ameliorate many diseases simultaneously. There are many parallels between different neurodegenerative disorders including atypical protein assemblies as well as induced cell death. Neurodegeneration can be found in many different levels of neuronal circuitry ranging from molecular to systemic.

Track 8: Brain Tumor and Neuro-oncology

Benign and malignant. Benign tumors are usually formed by slow-growing cells that hardly spread. Though they can press on and damage nearby normal tissue, benign tumors are less dangerous than malignant tumors. However, they can be dangerous if they endanger vital brain centres. However, over time, some benign tumors can become malignant. Malignant brain tumors, on the other hand, are formed by cells that typically grow quickly and are capable of invading nearby tissues and spreading to other parts of the body. Their tendencies to attack and spread make these tumors much more dangerous. Malignant tumors of the brain often spread to other parts of the central nervous system. Only relatively few spread to other parts of the body. The cause of most brain cancers is unknown. In general, cancers are due to a combination of inherited genetic factors coupled with some exposure during life, such as exposure to a chemical, a virus or radiation. Of these, the best case has been made for exposure to high doses of radiation, such as those given as part of cancer treatment, and an increased risk of subsequent brain cancer. Exposure to some chemicals in the workplace has also been found to increase the risk of developing brain cancer. Infections may play a role as well: the virus that causes mononucleosis, the Epstein-Barr virus, has been linked to an increased risk of a form of lymphoma that affects the central nervous system, CNS lymphoma, which also is more common among individuals infected with HIV, the virus that causes AIDS. Genetics play a particularly important role in a number of brain tumors that are clearly linked to a number of inherited disorders and disorders due to chromosome injury.

Track 9: Neuroplasticity

The recent neuroscience research proves that Neuroplasticity is the basis for brain working out exercises which revolutionized the brain health and science research. The ability of the Brain to alter at any age is referred to as Neuroplasticity or Brain Plasticity. There are about 600 Neurological disorders and approximately 50 million Americans are being affected each year. The main risk factors for Neurological disorders are genetic manipulation, age, lifestyle and other eco-friendly agents. Abnormalities in structural and biochemical functions cause various symptoms. Some of them are paralysis, seizures, confusion, muscle weakness and altered levels of consciousness. One of the fundamental principles underlying neuroplasticity is based on the idea that individual synaptic contacts are constantly being removed or recreated, largely dependent upon the activity of the neurons that bear them. The activity-dependence of synaptic plasticity is captured in the aphorism which is often used to summarize Hebbian theory: "neurons that fire together, wire together"/"neurons that fire out of sync, fail to link". If two nearby neurons often produce an impulse in close temporal proximity, their functional properties may converge. Conversely, neurons that are not regularly activated simultaneously may be less likely to functionally converge.

Track 10: Neuroprotection

Neuroprotection suggests to the relative storing of neuronal structure and/or function. In the case of an on-going insult (a neurodegenerative insult), the relative preservation of neuronal integrity implies a decreasing in the rate of neuronal loss over time, which can be expressed as a differential equation. It is a widely explored treatment option for many central nervous system (CNS) disorders including neurodegenerative diseases, spinal cord injury, stroke, traumatic brain injury and acute management of neurotoxin consumption (i.e. methamphetamine overdoses). Neuroprotection aims to prevent or slow disease progression and secondary injuries by halting or at least slowing the loss of neurons. In spite of contrasts in indications or wounds related to CNS clutters, numerous of the instruments behind neurodegeneration are the same. Common instruments incorporate expanded levels in the oxidative stretch, mitochondrial brokenness, excitotoxicity, provocative changes, press amassing, and protein aggregation. Of these instruments, neuroprotective medications regularly target oxidative stretch and excitotoxicity—both of which are greatly related with CNS disarranges. Not as it was can oxidative stretch and excitotoxicity trigger neuron cell passing but when combined they have synergistic impacts that cause indeed more debasement than on their own. In this way restricting excitotoxicity and oxidative push may be an exceptionally vital perspective of neuroprotection. Common neuroprotective medications are glutamate opponents and cancer prevention agents, which point to constrain excitotoxicity and oxidative.

Track 11: Neuroimmunology and Neurotransmitters

Neuroimmunology is a field combining neuroscience, the study of the nervous system, and immunology, the study of the immune system. Neuroimmunologists seek to better understand the interactions of these two complex systems during development, homeostasis and answer to injuries. A long-term aim of this rapidly developing research area is to further develop our understanding of the pathology of certain neurological diseases, some of which have no clear aetiology. In doing so, neuroimmunology contributes to the development of new pharmacological treatments for several neurological conditions. Many kinds of interactions involve both the nervous and immune systems including the physiological functioning of the two systems in health and disease, malfunction of either and or both systems that lead to disorders and the physical, chemical, and ecological stressors that affect the two systems on a daily basis. Neurotransmitters are endogenous chemicals that enable neurotransmission. It is a type of chemical messenger which transmits signals across a chemical synapse, such as a neuromuscular connection, from one neuron (nerve cell) to another "target" neuron, muscle cell, or gland cell. Neurotransmitters are released from synaptic vesicles in synapses into the synaptic cleft, where they are received by neurotransmitter receptors on the target cells. Many neurotransmitters are synthesized from simple and abundant precursors such as amino acids, which are readily available from the diet and only require a small number of biosynthetic steps for conversion. Neurotransmitters play a major role in shaping everyday life and functions. Their exact numbers are unknown, but more than 200 chemical messengers have been uniquely identified.

Track 12: Pediatric Stroke and Recovery

The major reason of death in children in the USA  is due to stroke and the most pediatric stroke survivors will be suffering from neurological or cognitive impairments. Because of the plasticity of the brains of children, they recover earlier than adults. A stroke survivor may be diagnosed with Epilepsy. Based on the cause of the stroke, the treatments will be decided by the physicians. Constraint therapy is an old therapy, but it is now widely used in pediatric stroke rehabilitation. If the stroke is caused by the blockage, then blood thinning medications will be given. If a stroke occurs due to Sickle Cell Disease (SCD), then an immediate blood transfusion will be performed. A physiotherapist can help with movement problems such as weakness or paralysis, spasticity or muscle spasms.  The therapist will assess and design a program to increase muscle strength (which can reduce the risk of spasticity) and movement. It is estimated that about 6 million deaths are due to cerebrovascular disorders. It is the second leading cause of death in the world and 6th most common cause of disability.

Track 13: Neuropsychiatry

Neuropsychiatry preceded the current disciplines of psychiatry and neurology, which had common training; however, psychiatry and neurology have subsequently split apart and are typically practised separately. Neuropsychiatry is thoroughly associated with the fields of behavioural neurology. Neuropsychiatry is the interface of Psychiatry and Neurology that deals with mental disorders, which in most cases can be shown to have their origin from an identifiable brain malfunction. Neuropsychiatry focuses to understand the link between the mind, body and its behaviour. Training in both neurological and psychiatric aspects of illness places Neuropsychiatry in a unique place to deliver this care. An effective evaluation of the clinical course of diseases requires the application of very precise diagnostic and assessment approaches as early as possible. By achieving these strategies, offers new chances for biomarker identification and/or discovery in complex diseases and may provide pathological pathways understanding for diseases beyond traditional methodologies.

Track 14: Stroke Nursing and Interventions

Nurses play an important role in all phases of care of the stroke patient. Some of the nurse caring plans are Ineffective Cerebral Tissue Perfusion, Impaired Physical Mobility, Impaired Verbal Communication, Disturbed Sensory Perception, Ineffective Coping, Self-Care Deficit, and Risk for Reduced Swallowing. Nurses may work as an emergency medical specialist (EMT) and paramedics, radio providers of online medical control to emergency medical services (EMS) personnel from base stations, and educators who teach EMS personnel about stroke and the care of stroke patients. Nurse Interventions are monitoring major signs in patients such as monitoring blood pressure, comparing BP reading in arms, heart rate, rhythm, and murmurs. There also monitor Respirations, noting patterns and rhythm, Cheyne-Strokes respiration

 

Market Analysis

Importance and Scope:

Neurological disorders become a growing threat, due to the demographic change and the resulting increase of elderly populations. The importance of this research cannot be inflated. More than 1,000 disorders of the brain and nervous system result in more hospitalizations and lost productivity than any other disease group, including heart disease and cancer. In 2007, the World Health Organization estimated that neurological disorders affect up to one billion people worldwide. In fact, neurological diseases make up 11 per cent of the world’s disease burden, not including mental health and addiction disorders The cost of these diseases is high across the globe. For example, the European Brain Council estimated in 2010 that neurological diseases in Europe alone cost one trillion dollars a year.

Advances in research could reduce these costs. Discovering how to delay the onset of Alzheimer's disease by five years could save $50 billion in annual health care costs in the United States alone. Given the ageing of many populations around the globe, the societal impact of Alzheimer’s is many times greater than financial resources it will take to cure.

Conferences, Workshops, Symposiums, Conventions pave the way to emanate and explore our ideas in congruent platforms for presuming the wholesome outcomes. We invite you to join us at the Mental Health 2018, where we assure you to have a significant experience with scholars from all around the world.

Increasing occurrence of malicious disorders including Parkinsonism and Alzheimer’s disease together with other inherited CNS disorders has resulted in increased necessity for new improvements in neuroscience industry. The market is expected to experience growth over the forecast period on account of growing demand in laboratories and academic centers. The market players aim at introducing unique technologies with the ability to obtain insights to understand better the compound nervous functionalities and neural manipulations. Furthermore, increasing aggregate geriatric population every year is anticipated to drive significantly the demand owing to a growing need for better treatment and medication.

Why in Abu Dhabi:

Abu Dhabi is the second most populous and capital the city of the UAE. Abu Dhabi rests on a T-shaped island jutting into the Persian Gulf. Abu Dhabi is the federal capital and centre of government in the United Arab Emirates. Abu Dhabi's rapid development and urbanisation is coupled with the relatively high average income of its population, has transformed the city into a large and advanced metropolis.

Currently, Abu Dhabi is the country's centre of political and industrial activities, and a major cultural and commercial centre, due to its position as the capital. Its focus on oil exports and commerce is reflected by the skyline’s modern towers and shopping mega centres such as Abu Dhabi and Marina malls.

Various tourist attractions of Abu Dhabi include Emirates Palace, Yas Marina Circuit, The Corniche, Etihad Towers, Mangrove Kayaking Tours, Ferrari World, Boat Tours, Observation Deck at 300, Qasr Al-Hosn, Abu Dhabi Falcon Hospital, Yas Water World, Yas Island, Emirates Park Zoo, Saadiyat Cultural District, Heritage Village and Liwa Oasis.

Beneath white-marble domes, the vast Sheikh Zayed Grand Mosque features an immense Persian carpet, crystal chandeliers and capacity for 41,000 worshipers. The Sheikh Zayed Grand Mosque is the major sightseeing attraction and wows all who visit. But the city also makes a good base for excursions to the desert landscapes of Liwa Oasis and the oasis city of Al Ain.

Target Audience:

Directors, Neurologist, Neurosurgeons, Psychiatrist, Head of department, Professors and Students from Academia in the research of Neuroscience. Neurophysiologists, Neurologists, Neurosurgeons, psychiatrists, physiatrists, Pharmacists, Research scientists, Neurology Organizations and societies, Pharmaceutical (drug design and discovery) companies, Neuro and CNS drug Industries, Neuroscience associations & foundations, Professors and Students from Academia in the study of Neurology and Neurophysiology and researchers who utilize neurophysiological techniques and knowledge in the diagnosis and management of patients with disorders of the nervous system, Doctors, Clinical organizations, Neuroscience institutions,  Educational institutions, Healthcare professionals.

Target Audience:

Academia   60%

Industry      30%

Others         10%

Universities associated with Neurology and Neurosurgery in World:

Stanford University

University of California

University of South Carolina Beauport

University of Helsinki

California Institute of Technology

Yale University

Harvard University

University of Pennsylvania

University of Chicago

The Kavli Institute for Brain Science

Cornell University

Dalhousie University

Leiden University- Neither land

Temple University USA

University Oklahoma

Boston Coll USA

Florida International University

King Saud University

Ain Shams University

American University of Beirut

Alfaisal University

Mansoura University

King Abdulaziz University

Assiut University

University of Edinburgh

University of Manchester

Cardiff University

University of Vermont

University of Amsterdam

Ghent University

Maastricht University

University of Melbourne

University of Queensland

University of New South Wales

University of Adelaide

University of Sydney

United Arab Emirates University

Middlesex University, Dubai

NYU Abu Dhabi

Zayed Universities

Kuwait University

New York University Abu Dhabi

University of Sharjah

Abu Dhabi University

German Neuroscience Center         

Who to attend:

Neurophysiologists, Neurologists, Paediatric Neurologists, Neurosurgeons, physiatrists, Research scientists, Neurology Organizations, and Epileptologists Pharmaceutical companies, Neuro and CNS drug Industries, Neuroscience associations, Neuroscience  foundations, neuroradiologists,  Professors, Students from Academia in the study of Neurology and Neurophysiology and researchers who utilize neurophysiological techniques and also  knowledge in diagnosing and in treating nervous system disorders, social workers.

Why attend?

Neuology and Therapeutics is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Brain disorders.

Global Market Analysis of Stroke and Neurological Disorders:

The market analysis of  stroke and neurology represent the largest and untapped market in medicine sector. This estimated market analysis is based on probability of approval and sales of products in late stage development, demographic trends and marketing of product. Emerging markets once again helps to boost revenues. CNS therapeutics comprise approximately 15% of total pharmaceutical sales, nearly $30 billion worldwide.

An estimated annual economic costs of anxiety disorders, depression, and schizophrenia are $47 billion, $44 billion, and $33 billion per year approximately. The goal of this session is to understand the market Value & Growth of Neurology Drugs , Current economics cost of clinical research and development.

fig : Global analysis of stroke and neurological disorders.

 

 

 

Related Conferences:

Associations:

USA

American Stroke Association | National Stroke Association | Heart and Stroke Foundation of Canada | North Carolina Stroke Association | American Association of Neurological Surgeons | American Academy of Neurology | Canadian Stroke Consortium | Canadian Stroke Network | Intermountain Stroke Center | National Stroke Association | Merican Society of Neuro-rehabilitation | USAAneurysm Foundation& Brain Injury Association of America | Huntington's Disease Society of America and Hydrocephalus AssociationUnited Spinal Association& Vascular Birthmarks Foundation | American Society for Neurochemistry | The Canadian Society of Pharmacology and Therapeutics | American Society for Pharmacology and Experimental Therapeutic | Epilepsy Foundation of America.

Europe:

German Stroke Society | European Stroke Organization | World Federation of Neurology | World Stroke Organization | The Brain Injury Association | Mediterranean Stroke Society | European Federation of Neurological Associations | Spanish Society of Neurology | European neurological society | European Academy of Neurology | National Stroke Association of Russian Federation | Central and East European Stroke Society | Romanian National Stroke Association (RNSA) | British Columbia Society of Electroneurophysiology | Technologists Alzheimer Europe | British Columbia Society of Electro Neurophysiology Technologists | British Paediatric Neurology Association | The British Association of Stroke Physicians | Danish Neurological Society |Dutch Society of Neurology | The Association of British Neurologists| British Neuro-Oncology Society;Italian Neurological Society| Italian Stroke Society | British Acoustic Neuroma Association (BANA)(UK)

Asia Pacific & Middle East

Emirates Neurology Society (EMINS) | Emirates Nursing Association,Emirates Cardiac Society | Association of Neurophysiological Scientists | Iraqi Neurological Association (INA) - Iraq (IQ) | Israel Society for Neuroscience - Israel (IL) Society for Arab Neuroscientists | Middle East Spine Society | Mediterranean Neuroscience Society | North Africa and the Middle East - Society for Neuroscience | The Pan Arab Neurosurgical Society | Emergence of Cognitive Neuroscience in The Middle East | Middle East Neurosurgical Society | The Saudi Critical Care Society;  Walter E. Dandy Neurosurgical Society; Philippine Neurological Association (PNA) | Malaysian Society of Neurosciences | Neurological Society of India | Neurological Surgeon Society of India (NSSI) | Clinical Neuroscience Society Singapore | The Japan Stroke Society | Asian Pacific Society for Neurochemistr | Indian Society of Neuro-Oncology |Indian Pharmacological Society

Past Conference Report

Stroke Meet 2018

5th Annual Conference on Stroke and Neurological Disorders was organized during November12-13, 2018 at Istanbul, Turkey with the support and contribution of the Organizing Committee Members.

Firstly we must thank you for trusting us and participating at Stroke Meet 2018, a global platform to discuss various important aspects of Neurology.

There are infinite reasons to extend our gratitude to you for making the Stroke Meet 2018 outstanding conference. We couldn't have done it without your continuous support and believe towards our organization, which mutually made to achieve Stroke Meet 2018 new heights in the field of Neuroscience.

The conference was marked by the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 15 countries, who have driven this event into the path of success.   

The conference was organized around the theme “Building a Better World without Disorders”. The event implanted a firm relation of upcoming strategies in the field of Novel approaches and Developments in Neurological Disorders and Stroke with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers Wagih El Masri, Keele University, USA, Umur A Kayabasi, Bahcesehir University, Turkey, Tayfun Uzbay, Uskudar University, Turkey and Yavuz Selim Silay, ICG(Istanbul Consulting Group), Turkey.

The conference witnessed an amalgamation of peerless speakers, Keynote speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neurological Disorders and Stroke through their fabulous presentations at the podium of Stroke Meet 2018.   

Conference series LLC offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners, sponsors and Editorial Board Members of Journal of Neurology,  Journal of Brain Disorders & Therapy and  Journal of Brain Tumors & Neurooncology who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

So as a continuation of Stroke Meet 2018, we would like to heartily invite you to our upcoming 6th Annual Conference on Stroke and Neurological Disorders to be held in Abu Dhabi, UAE on November 25-26, 2019.

For 2019 we are expanding our focus towards all aspects of Neurological Disorders and Stroke Re­search findings. Our organizing committee is gearing up with more innovative and explorative sessions to unleash the boundaries of the Neurological Disorders and Stroke.

Your expertise and knowledge in the area of Neurological Disorders and Stroke will provide an oppor­tunity to discuss and respond to a series of questions about the status of advanced Neurological Disorders and Stroke therapeutics.

Stroke is ranked as the second leading cause of death in Dubai. In the Middle East and North Af­rica, stroke is emerging as a major health problem, with the death rate from it will be double by 2030. In 2013 alone, U.A.E. healthcare expenditures reached an estimate of $ 16.8. The healthcare market of the UAE is expected to expand at a CAGR of over 16% during 2011-2014 on back of neurological disorders. About $ 177.5 million revenue generated from medical tourism in 2012, which may rise to $ 710 million by 2020. FDA submitted drug market report on central nervous system disorders which is estimated $78 billion in 2010 and to reach nearly $81.8 billion by 2015. The market survey forecast of neurological disorders is more than $500 billion per year and also the cost of stroke care is expensive too.

We would like to organize this conference with your support to gather all the Neurological Disorders and Stroke researchers in a single platform, hope we will be honoured with your support to organize Stroke 2019 in a grand level, your support will be the key of success for our next year conference.

We look forward to seeing your benign presence with active contribution and support to make this event successful once more.

Once again it’s our pleasure to welcome you to our upcoming 6th Annual Conference on Stroke and Neurological Disorders to be held in Abu Dhabi, UAE on November 25-26,2019.

 

 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 25-26, 2019

For Sponsors & Exhibitors

sponsorships@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Neurological Disorders Brain Disorders & Therapy Journal of Tumour Research & Reports

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Addiction Psychiatry
  • Alzheimer Disease
  • Aminoacid
  • Amyloid Hypothesis
  • Amyotrophic Lateral Sclerosis
  • Arteries
  • Artherosclerosis
  • Astrocyte
  • Autonomic Neuropathy
  • Benign Tumors
  • Bipolar Disorder
  • Blood-brain Barrier
  • Brain
  • Central Nervous System
  • Cerebral Edema
  • Cerebral Tissue
  • Cerebrovascular
  • Cerebrovascular Disease
  • Cerebrum
  • Cheyne-Stokes Respiration.
  • Coagulation
  • Dementia
  • Depersonalization
  • Depression
  • Diffusion
  • Disorders
  • Endogenous
  • Epidemiological
  • Epidemiology
  • Epilepsy
  • Epylepsy
  • Excitotoxicity
  • Extracellular Fluid
  • FMRI
  • Guillain Barre Syndrome
  • Haemorrhagic Stroke
  • Holistic Psychiatry
  • Homeostasis
  • Hypertension
  • Hypoperfusion
  • Inflammatory
  • Intervention
  • Ischemic Assault
  • Ischemic Stroke
  • Lymohoma
  • Maladies
  • Malignant Tumor
  • Migraines
  • Motor Neuron Diseases
  • MRI
  • Multiple Sclerosis
  • Muscle Cell
  • Nerve
  • Nervous System
  • Neurodegenerative
  • Neurogenesis
  • Neuroimmunological
  • Neuroplasticity
  • Neuroprotection
  • Neuropsychiatry
  • Neurosarcoidosis
  • Oncology
  • Paralysis
  • Parkinson Disease
  • Pediatric
  • Pediatric Stroke
  • Peptides And Purines
  • Peripheral Nervous System
  • Peripheral Neuropathy
  • PET
  • Phobias
  • Physiotherapy
  • Pseudo-bulbar Effect
  • Psychoanalysis
  • Psychopathology
  • Receptors
  • Rehabilitation
  • Sickle Cell
  • Spasticity
  • Spinal Cord
  • Stroke
  • Synapse
  • Synaptic Cleft
  • Tomography
  • Transfusion
  • Vertebral Stenosis